Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Madison, Wisconsin 53792


Purpose:

This pilot study will investigate the safety and effect of etanercept in HIV infection by studying HIV replication and immune function (as measured by CD4 counts) in individuals with HIV infection.


Criteria:

Inclusion Criteria: - Adults greater than 18 years of age with documented HIV infection - Highly active antiretroviral therapy (HAART) regimens as defined by the Department of Health and Human Services guidelines; stable regimens for 12 weeks. - CD4 greater than 200 at time of study enrollment - Stable monitoring labs (hematology survey with differential, ALT, creatinine) - Absolute neutrophil count within normal limits Exclusion Criteria: - AIDS defining illness within the last 6 months - Acute bacterial, viral, or fungal infection within the last 1 month, or history of recurring infections - Women who are pregnant or nursing - Hypersensitivity to etanercept - Previous use of etanercept - Acute malignancy in the last 5 years excluding in situ cervical cancer (CA) and common skin cancers (non melanoma) - History of active or latent tuberculosis - History of demyelinating nerve disease - History of seizure disorder - Latex allergy - Subject has any of the following laboratory values within 30 days of baseline: - hemoglobin concentration < 10.0 g/dl for men and < 9.0 g/dl for women - platelet count < 75,000/mm3 - AST or ALT > 5x upper limit of normal (ULN) - serum creatinine > 2.5x ULN - serum pancreatic amylase > 1.5 ULN - Subject requiring treatment with immunomodulating agents, such as systemic corticosteroids, interleukins, vaccines, or interferon - Subjects who chronically use any over-the-counter (OTC) or prescription medication (except vitamins) must not change the regimen or switch their medication within 3 days of drug administration and until discharged from the study.


NCT ID:

NCT00205231


Primary Contact:

Principal Investigator
Andrew Urban, MD
University of Wisconsin, Madison


Backup Contact:

N/A


Location Contact:

Madison, Wisconsin 53792
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.